I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

External beam radiation therapy (EBRT) for breast cancer is usually delivered using parallel-opposed lateral and medial tangential portals. The treatment volume with tangential fields includes a significant volume of heart and left anterior descending artery (LAD) resulting in radiation-induced late cardiac effects. The probability of cardiotoxicity is further amplified by the systemic chemotherapy. Modern treatment techniques such as computed tomography (CT) simulation and conformal techniques of radiotherapy reduce the cardiac dose by decreasing the coverage of target volumes or large volumes of heart receiving low dose radiation. This low-dose tissue bath can result in detrimental effects. Thus, it is appropriate to minimize the cardiac dose to the least possible.

Several studies suggested the deep inspiration breath-hold technique (DIBH) to reduce the radiation dose to the heart by displacing the breast/chest wall away from the heart during treatment.\[[@ref1][@ref2]\] This technique is associated with lower cardiac dose without compromising the target coverage.\[[@ref3][@ref4][@ref5]\] Studies have reported a reduction of heart and lung doses when comparing DIBH, as well as other gating techniques, to free breathing (FB) in both dose planning and clinical studies.\[[@ref6][@ref7]\]

In this study, heart doses are compared between three-dimensional radiotherapy (3DCRT) and intensity modulated radiotherapy (IMRT) techniques with and without DIBH.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

This was a single institutional prospective study conducted between June 2014 and April 2016. In this study, 15 newly diagnosed patients with left side breast cancer with no breathing difficulty treated with adjuvant EBRT were recruited. All patients provided informed consent for the proposed treatment. Clearance from the institutional ethical board and scientific committee board was obtained.

Immobilization and computed tomography simulation {#sec2-1}
-------------------------------------------------

Patients were immobilized in supine position using angled breast board with 10--15° inclination, with both arms abducted above shoulder and head turned to contralateral side. Post-operative surgical scars, medial and lateral borders were marked with thin radio-opaque wire. Patients were coached about the breath hold acquisition technique. Breath-hold amplitude was monitored using Varian Real time Position Management (RPM) system (Varian Medical Systems, Palo Alto, CA, USA). This system uses a perspex box with infrared markers as an external surrogate which is tracked by an infrared camera situated at the end of the CT couch. The marker was placed on the midline anterior abdominal wall at the level of the diaphragm outside the treatment area. The breath hold was analyzed on RPM monitor, and upper and lower gate thresholds were adjusted ensuring the maximum acceptable movement within these thresholds was 5 mm. Once the patient was comfortable, FB and DIBH planning CT scans of 5 mm slice thickness were acquired.

Delineation of target volumes and organs at risk {#sec2-2}
------------------------------------------------

Clinical target volume (CTV) for the breast/chest wall and nodal regions were delineated on both FB and DIBH scans according to Radiation Therapy Oncology Group breast cancer atlas. The chest wall CTV was expanded 5 mm to create chest wall planning target volume (PTV), keeping anterior and posterior borders unchanged to account for build-up region, and to spare the underlying normal lung from high dose radiation. The breast CTV was expanded to breast PTV and it was cropped 3 mm anteriorly from skin to minimize high-dose levels in the build-up regions for IMRT plans.

Organs at risk {#sec2-3}
--------------

The organs at risk (OARs) such as heart, LAD, left lung, contralateral breast and spinal cord were contoured on both FB and DIBH scans. Heart contouring was done using Feng *et al*. cardiac atlas.\[[@ref8]\] LAD was contoured and planning organ at risk volume (PRV) margin of 3 mm was added to account for uncertainties of motion and respiration.

Treatment planning {#sec2-4}
------------------

Planning was performed using the Varian Eclipse™ Treatment Planning System Version 8.9 (Varian Medical Systems, Palo Alto, CA) using anisotropic analytical algorithm. The prescription dose was 50 Gy in 25 fractions at 2 Gy per fraction. Both 3DCRT and IMRT plans were generated on both FB and DIBH data sets, thus creating 4 plans (3DCRT~FB~, 3DCRT~DIBH~, IMRT~FB~ and IMRT~DIBH~). The dose rate for 3DCRT was 600 monitoring units (MU)/min and for IMRT 400 MU/min.

3DCRT {#sec2-5}
-----

In this technique, the mono-isocentric irradiation with opposing tangential photon fields for breast/chest wall and anterior portal for supraclavicular region with 6 MV energy was used. The isocenter was set at the junction of supraclavicular and tangential fields. To avoid the divergence of tangential fields into lung, half beam blocks were created with asymmetric collimator jaws. Using digitally reconstructed radiograph images, gantry angle was determined to ensure adequate coverage of the target volume along with the least volumes of lungs, heart, and contralateral breast within the treatment field. Critical organs were shielded using multileaf collimators (MLC) without compromising PTV coverage. Opposing lateral tangential field was created. Homogeneous dose distribution was obtained by field-in-field technique and by adjusting field weights.

The supraclavicular field was angled at 340--345° to protect the spinal cord and the esophagus. Two different dose normalization points were used in this three-field technique.

IMRT {#sec2-6}
----

IMRT plans included six beams with fixed jaws, using dynamic MLCs, starting from 320° and equally spaced every 40° to cover breast/chest wall (320°, 0°, 40°, 80°, 120°, and 160°). Beams were coplanar with the collimator angle set to 0°. Beams and angles were kept the same for all patients for uniform comparison. Treatment plans were designed so as to cover the PTV by at least 95% of the prescribed isodose and meet the OARs dose constraints. No MU constraint was used to allow sparing of OARs.

Dosimetric evaluation parameters {#sec2-7}
--------------------------------

In this study, a total of 60 plans (4 sets - 3DCRT~FB~, 3DCRT~DIBH~, IMRT~FB,~ and IMRT~DIBH~) were generated and evaluated. Dosimetric parameters were compared between the sets of plans. Dose-volume histogram (DVH) parameters were compared between plans for each FB and DIBH scan with 3DCRT and IMRT based on OAR doses: mean dose to heart (Heart~Dmean~), volume of heart receiving 5 Gy, 10 Gy, 20 Gy, and 25 Gy (Heart V~5~, Heart V~10~, Heart V~20~, Heart V~25~, respectively), mean and maximum dose to LAD (LAD~Dmean~ and LAD~Dmax~, respectively), mean and maximum dose to LAD PRV (PRV LAD~Dmean~ and PRV LAD~Dmax,~ respectively), mean dose to ipsilateral lung (Lung~Dmean~), volume of ipsilateral lung receiving 10 Gy and 20 Gy (Lung V~10~ and Lung V~20~, respectively), and mean dose to contralateral breast (Contra Breast~Dmean~).

The mean dose to PTV (PTV~Dmean~), Conformity Index (CI) and Homogeneity Index (HI) were reported and compared.

The CI as defined in ICRU 83\[[@ref9]\] is,

CI = Volume of PTV covered by the 95% isodose curve/Volume of PTV.

(CI of 1.0 is ideal).

The HI as defined in ICRU 83\[[@ref9]\] is,

(HI) = (D~2%~-D~98%~)/D~50%~

(HI of zero is ideal); where, D~2%~, D~98%~, D~50%~ are doses received by 2%, 98%, 50% of volume, respectively.

Statistical analysis {#sec2-8}
--------------------

Continuous variables are presented as a mean and standard deviation. The comparisons between the groups were performed using two-tailed pairwise Wilcoxon signed rank tests. All statistical computations were carried out using Statistical Package for the Social Sciences version 20.0 (SPSS version 20, SPSS Inc., Chicago, IL, USA). The value of *P* \< 0.05 was considered to indicate statistically significant difference.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

The comparison of target coverage and doses to OARs between the plans are summarized in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

###### 

Comparison of target volume coverage, conformity index, homogeneity index and monitoring units between the plans

![](JMP-42-123-g001)

###### 

Comparison of organs at risk doses - mean and standard deviations between the plans

![](JMP-42-123-g002)

The comparison of dose distribution and DVH between four plans generated for a single patient are shown in Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}.

![The comparison of dose distribution between four plans generated for a single patient](JMP-42-123-g003){#F1}

![The comparison of dose volume histogram between four plans generated for a single patient (Pink-Right Breast, Green-Heart, Brown-left Lung, Yellow-left anterior descending artery)](JMP-42-123-g004){#F2}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

There are studies reporting the cardiac sparing benefits of IMRT over 3DCRT and DIBH over FB in 3DCRT. There are few studies comparing FB and DIBH techniques when incorporated in IMRT and 3DCRT to evaluate cardiac and LAD-CA doses. The results in two such studies, evaluating 3DCRT and IMRT with and without DIBH showed contradictory results.\[[@ref10][@ref11]\] The current study is another attempt to explore further on this issue on whether the use of IMRT resulted in an additional decrease of the cardiac dose as well as a further decrease in the dose to LAD-CA, in cases with and without the use of DIBH.

Radiation-induced cardiac toxicity depends on the dose and volume of cardiac exposure. Quantitative Analyses of Normal Tissue Effects in the Clinic suggests the Heart V~25~ to be \<10% to decrease the cardiac mortality to \<1%. It is achieved in the current study with all the four plans. In the present study, cardiac dose reduction with DIBH was evaluated and compared between 3DCRT and IMRT. 3DCRT was found to be a simpler method than inverse IMRT to provide a homogeneous dose distribution and lower doses to OARs.

With DIBH, we found a statistically significant reduction in all dose-volume parameters specified for the heart, with maximal sparing with 3DCRT~DIBH~ amongst all 4 plans (3DCRT~DIBH~, IMRT~DIBH~, 3DCRT~FB~ and IMRT~FB~). IMRT significantly increased the low dose cardiac tissue bath (Heart V~5~) by 90% compared to 3DCRT irrespective of breathing technique. Heart V~20~ and Heart V~25~ were not significantly different between IMRT and 3DCRT, whether delivered by DIBH or FB techniques.

In a systematic review by Latty *et al*., the reduction in Heart~Dmean~ ranged from 26% to 75% in 3DCRT~DIBH~ and IMRT~DIBH~.\[[@ref12]\] In our study, DIBH technique reduced the Heart~Dmean~ by 53.5% in 3DCRT plans and by 14.5% in IMRT plans compared to FB technique. Using DIBH, 3DCRT reduced Heart~Dmean~ by 67.6% over IMRT. In 3DCRT~DIBH~ there was a reduction in the LAD~Dmean~ by 28.5% compared with 3DCRT~FB~. IMRT~FB~ and IMRT~DIBH~ further lowered the LAD~Dmean~ by 30% and LAD~Dmax~ by 18% compared with 3DCRT~DIBH~. This was because of the proximity of the LAD to the target volume, resulting in higher doses even with 3DCRT~DIBH~ plans.

In a systematic review by Smyth *et al*., the cardiac dose sparing benefits of DIBH are reported with 3DCRT and IMRT.\[[@ref13]\] With DIBH, the reduction in Heart~Dmean~ ranged from 38% to 67% and the reduction in LAD~Dmean~ ranged from 31%-71%. Our results are consistent with their findings. Furthermore, our study has shown the dosimetric superiority of 3DCRT~DIBH~ over rest of the 3 techniques (3DCRT~FB~, IMRT~FB~ and IMRT~DIBH~) in terms of better sparing of heart, lung as well as the contralateral breast. However, we observed the lowest LAD doses with IMRT~DIBH.~ In a study by Trifiletti *et al*., 3DCRT~DIBH~ produced maximal sparing of heart compared with IMRT.\[[@ref10]\] In another similar study by Bolukbasi *et al*., 3DCRT~DIBH~ better spared the heart, LAD and contralateral breast compared to inverse IMRT.\[[@ref14]\] Our results are consistent with these studies, with regards to heart, left lung and contralateral breast. However, IMRT further lowered the LAD~Dmean~ dose compared to 3DCRT~DIBH~.

In the current study, all dose-volume parameters of the lung were lowest with 3DCRT~DIBH~ over rest of the three plans. The reduction in Lung~Dmean~ was 16% with 3DCRT~DIBH~ compared with 3DCRT~FB~, and 5% with IMRT~DIBH~ compared with IMRT~FB~. IMRT~DIBH~ significantly increased the Lung~Dmean~ and Lung V~20~ by 27% and 23.6% respectively over 3DCRT~DIBH~, again showing the dosimetric superiority of 3DCRT~DIBH~ over rest of the three plans.

The risk of late second malignancies is a concern when IMRT is used, as a result of increased healthy tissue being exposed to higher doses and increased MUs delivered.\[[@ref15]\] One such example of second malignancy is contralateral breast cancer which may develop years later after the irradiation. In the current study, IMRT plans increased the Contralateral Breast~Dmean~ by 91% over 3DCRT, irrespective of breathing techniques. 3DCRT~DIBH~ technique in our study resulted in significantly higher delivery of MUs than in 3DCRT~FB~. Breathing techniques chosen made no significant difference in MUs in IMRT plans. However, 3DCRT fared better in this regard than IMRT when delivered with DIBH technique. Although IMRT delivered more conformal plans, it is at the potential increased risk of second malignancies by virtue of delivering higher MUs. This issue is all the more important when women of age \<40 years are delivered IMRT.

Thus, in our study, we found the dosimetric superiority of 3DCRT~DIBH~ over rest of the plans with regard to better sparing of OARs and with adequate target volume coverage. Hence, we conclude that 3DCRT~DIBH~ is the preferred technique for left-sided breast cancer irradiation. Studies are required to report the long-term clinical outcomes of DIBH technique in left breast irradiation, as all the present studies are dosimetric. Studies reporting cardiac dose-volume responses to radiation are also required, to assess the cardiac dose to be minimized.

There are some limitations of the current study. First, the sample size of this study was relatively small. Second, this study involves dose measured from the TPS. However, any independent dose verification using phantom study would have given more accurate dose measurement. Third, *in-vivo* dose verification of the contralateral breast was not done due to in availability of *in vivo* dosimeters at our institute.

C[ONCLUSIONS]{.smallcaps} {#sec1-5}
=========================

Both 3DCRT and IMRT have shown optimum target coverage with a superior CI and HI with IMRT plans. However, the 3DCRT~DIBH~ plan has been shown to spare all the OARs, especially heart to the maximum extent compared with rest of the plans as the IMRT plans (both IMRT~DIBH~ and IMRT~FB~) contribute higher integral doses to the ipsilateral lung and contralateral breast.
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